Beneficial and adverse effects of high-dosage MZR therapy in the management of children with frequently relapsing nephrotic syndrome

Japanese Journal of Nephrology

Volumn 48, Issue 4, 2006, Pages 365-370

  Goto, Miwa ^a   Ikeda, Masahiro ^c   Hataya, Hiroshi ^c   Ishikura, Kenji ^c   Hamasaki, Yuko ^c   Honda, Masataka ^b  

^a TOKYO METROPOLITAN CHILDREN'S MEDICAL CENTER   (Japan)

^b Tokyo Metropolitan Hachioji Children's Hospital   (Japan)

^c NONE

Author keywords

Children; Frequently relapsing nephrotic syndrome; Mizoribine (MZR); Safety; Therapy

Indexed keywords

MIZORIBINE; PREDNISOLONE;

ADOLESCENT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; HYPERURICEMIA; LONG TERM CARE; MALE; NEPHROTIC SYNDROME; RELAPSE; SCHOOL CHILD; STATISTICAL ANALYSIS; UNSPECIFIED SIDE EFFECT;

ADOLESCENT; ADULT; CHILD; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; NEPHROTIC SYNDROME; PREDNISOLONE; RECURRENCE; RETROSPECTIVE STUDIES; RIBONUCLEOSIDES;

EID: 33745669334     PISSN: 03852385     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (6)